Literature DB >> 21710297

Pancreatic polypeptide meal response may predict gastric band-induced weight loss.

Andrew F R Dixon1, Carel W le Roux, Mohammad A Ghatei, Stephen R Bloom, Toni L McGee, John B Dixon.   

Abstract

BACKGROUND: Unknown hormonal and neural satiety signals are thought to drive sustainable weight loss following laparoscopic adjustable gastric banding (LAGB). The objective of this study was to investigate whether the structurally related satiety hormones pancreatic polypeptide (PP) and peptide YY (PYY) influence total percentage weight loss after LAGB.
METHODS: A cross-sectional study examined 17 postoperative individuals who had already achieved a mean of 28% LAGB-induced weight loss (range, 10-38%). A prospective study assessed plasma PP and PYY meal responses in 16 obese individuals prior to LAGB.
RESULTS: In the cross-sectional study, individuals with higher weight loss had lower PP meal responses (2-h AUC, R = -0.60, p = 0.01) and lower fasting PYY levels (R = -0.55, p = 0.02). In the prospective study, subsequent mean weight loss was 20% (range, 5-50%) after a mean of 53 months. Low preoperative PP meal response (2-h AUC) predicted significantly higher subsequent weight loss after LAGB (R = -0.56, p = 0.024). The eight individuals with the lowest PP meal response lost more weight than the eight with the highest PP meal response (median 25% vs. 14%, p = 0.004). When compared across all three groups, mean PP meal responses did not differ. Fasting PYY levels, however, were significantly lower in the postoperative group compared to the group tested pre-operatively, or the BMI-matched controls (-30%, p = 0.03).
CONCLUSIONS: PYY appears reduced in proportion to weight loss following LAGB, possibly representing attempted orexigenic homeostatic compensation. Although PP responses appear unchanged by weight loss status, low PP meal response may predict higher weight loss. PP meal response may be a biological marker that could predict an individual's susceptibility to the mechanism underlying LAGB-induced weight loss.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21710297     DOI: 10.1007/s11695-011-0469-z

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  46 in total

Review 1.  Role of gut hormones in obesity.

Authors:  Channa N Jayasena; Steve R Bloom
Journal:  Endocrinol Metab Clin North Am       Date:  2008-09       Impact factor: 4.741

2.  One-year experience with Tantalus: a new surgical approach to treat morbid obesity.

Authors:  Arthur Bohdjalian; Gerhard Prager; Ricardo Aviv; Shai Policker; Karin Schindler; Silke Kretschmer; Raphaela Riener; Johannes Zacherl; Bernhard Ludvik
Journal:  Obes Surg       Date:  2006-05       Impact factor: 4.129

3.  Vagotomy as a treatment for morbid obesity.

Authors:  J G Kral
Journal:  Surg Clin North Am       Date:  1979-12       Impact factor: 2.741

4.  Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels.

Authors:  Judith Korner; William Inabnet; Irene M Conwell; Carmen Taveras; Amna Daud; Lorraine Olivero-Rivera; Nancy L Restuccia; Marc Bessler
Journal:  Obesity (Silver Spring)       Date:  2006-09       Impact factor: 5.002

5.  Insulin, glucose, and pancreatic polypeptide responses to a test meal in restricting type anorexia nervosa before and after weight restoration.

Authors:  Kimberly P Kinzig; Janelle W Coughlin; Graham W Redgrave; Timothy H Moran; Angela S Guarda
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-01-30       Impact factor: 4.310

6.  Five- to eight-year results of truncal vagotomy and pyloroplasty for duodenal ulcer.

Authors:  J C Goligher; C N Pulvertaft; T T Irvin; D Johnston; B Walder; R A Hall; J Willson-Pepper; T S Matheson
Journal:  Br Med J       Date:  1972-01-01

7.  Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device.

Authors:  M Camilleri; J Toouli; M F Herrera; B Kulseng; L Kow; J P Pantoja; R Marvik; G Johnsen; C J Billington; F G Moody; M B Knudson; K S Tweden; M Vollmer; R R Wilson; M Anvari
Journal:  Surgery       Date:  2008-05-09       Impact factor: 3.982

8.  Effect of cephalic-vagal stimulation on insulin, gastric inhibitory polypeptide, and pancreatic polypeptide release in humans.

Authors:  I L Taylor; M Feldman
Journal:  J Clin Endocrinol Metab       Date:  1982-12       Impact factor: 5.958

9.  Inhibition of food intake in obese subjects by peptide YY3-36.

Authors:  Rachel L Batterham; Mark A Cohen; Sandra M Ellis; Carel W Le Roux; Dominic J Withers; Gary S Frost; Mohammad A Ghatei; Stephen R Bloom
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245

10.  Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.

Authors:  Carel W le Roux; Simon J B Aylwin; Rachel L Batterham; Cynthia M Borg; Frances Coyle; Vyas Prasad; Sandra Shurey; Mohammad A Ghatei; Ameet G Patel; Stephen R Bloom
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

View more
  5 in total

Review 1.  Medical devices for the treatment of obesity.

Authors:  Phong Ching Lee; John Dixon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-07-12       Impact factor: 46.802

2.  Solid versus liquid-satiety study in well-adjusted lap-band patients.

Authors:  Laura V Jones; Kay M Jones; Chris Hensman; Ruth Bertuch; Toni L McGee; John B Dixon
Journal:  Obes Surg       Date:  2013-08       Impact factor: 4.129

Review 3.  Metabolic surgery: action via hormonal milieu changes, changes in bile acids or gut microbiota? A summary of the literature.

Authors:  Timothy E Sweeney; John M Morton
Journal:  Best Pract Res Clin Gastroenterol       Date:  2014-08-12       Impact factor: 3.043

4.  The combination of GIP plus xenin-25 indirectly increases pancreatic polypeptide release in humans with and without type 2 diabetes mellitus.

Authors:  Sara Chowdhury; Songyan Wang; Bruce W Patterson; Dominic N Reeds; Burton M Wice
Journal:  Regul Pept       Date:  2013-10-29

Review 5.  Potential Hormone Mechanisms of Bariatric Surgery.

Authors:  Georgios K Dimitriadis; Manpal S Randeva; Alexander D Miras
Journal:  Curr Obes Rep       Date:  2017-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.